MYELOID MALIGNANCIES
Clinical trials for MYELOID MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new MYELOID MALIGNANCIES trials appear
Sign up with your email to follow new studies for MYELOID MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a targeted drug boost transplant success in older blood cancer patients?
Disease control Recruiting nowThis study tests whether adding venetoclax (a targeted pill) to standard chemotherapy before a donor stem cell transplant can improve outcomes for adults over 50 with acute myeloid leukemia or myelodysplastic syndrome. About 186 participants will be randomly assigned to receive e…
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 26, 2026 06:54 UTC
-
New hope: drug combo after transplant may keep childhood leukemia at bay
Disease control Recruiting nowThis study tests whether giving two drugs (decitabine and filgrastim) after a stem cell transplant can safely prevent cancer from coming back in children and young adults with acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), or related blood cancers. About 37 partic…
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE2 • Sponsor: Franziska Wachter • Aim: Disease control
Last updated May 26, 2026 06:53 UTC
-
Engineered immune cells take on tough blood cancers in new trial
Disease control Recruiting nowThis study tests a new treatment for people with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) that have come back or not responded to standard therapy. The treatment uses specially engineered natural killer (NK) cells designed to recognize and attack cancer cel…
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:44 UTC
-
New drug may keep blood cancer at bay after transplant
Disease control Recruiting nowThis study tests the safety of the drug olutasidenib given after a stem cell transplant to people with certain blood cancers (like AML or MDS) that have an IDH1 mutation. The goal is to see if this maintenance therapy can help prevent the cancer from coming back. About 31 adults …
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Supercharged immune cells take on relapsed blood cancers
Disease control Recruiting nowThis study tests a new treatment for people with certain blood cancers (myeloid malignancies) that have come back or not responded to standard therapy. It uses specially engineered immune cells from donated cord blood, combined with chemotherapy, to try to attack the cancer. The …
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:55 UTC